Supplementary Figure S1
Upper panel, A 384-well plate showing calculated growth of SGY1528 yeast expressing K 2P 2.1 (TREK-1) after 48 hour incubation in 2 mM KCl media in the presence of library compounds (10 µM, 1% DMSO) and controls. Growth was assessed by measuring fluorescence (560 nm excitation / 590 nm emission) after the addition of the vital dye Alamar Blue at the end of incubation. The numbers show percent of growth inhibition caused by the compounds relative to 1% DMSO or 0.1% SDS (0 and 100% inhibition controls, respectively). Lower panel, Summary table showing assay performance statistics.
Supplementary Figure S2
Exemplar K 2P 2.1 (TREK-1) inhibitors A, ML45 and B, ML58 identified in the high-throughput yeast screen. Panels show from left to right: chemical structure; HTS score, percent of growth inhibition for the indicated compound in the high-throughput screen; SMILES and chemical names; and activity. Activity plots show the effect of the compounds at the indicated concentrations against K 2P 2.1 (TREK-1) measured by two-electrode voltage clamp in Xenopus oocytes in 90 mM [K + ] o , pH 7.4. Currents were elicited by a ramp from -100 to 50 mV from a 0 mV holding potential. Values shown were taken at +40 mV.
Supplementary Figure S3
Exemplar K 2P 2.1 (TREK-1) activators A, ML12, B, ML42, and C, ML67 identified in the high-throughput yeast screen. Panels show from left to right: chemical structure; HTS score, percent of growth inhibition for the indicated compound in the high-throughput screen; SMILES and chemical names; and activity. Activity plots show the effect of the compounds at the indicated concentrations against K 2P 2.1 (TREK-1) measured by two-electrode voltage clamp in Xenopus oocytes in 90 mM [K + ] o , pH 7.4. Currents were elicited by a ramp from -100 to 50 mV from a 0 mV holding potential. Values shown were taken at +40 mV.
Supplementary Figure S5
Exemplar responses (at 0 mV) of A, K 2P 10.1 (TREK-2) and B, K 2P 4.1 (TRAAK) to the indicated concentration of ML67-33 measured by two-electrode voltage clamp in Xenopus oocytes in 2 mM [K + ] o pH 7.4. Currents were elicited by a voltage ramp from -150 to 50 mV, from a holding potential of -80 mV. Currents were elicited by a step protocol from -120 to 60 mV, in 20 mV increments, from a holding potential of -80 mV. Z measures the spread of test compounds away from the 100% inhibition controls 3 . Z-factor is often < Z'-factor. A positive Z-factor suggests that the bulk population of test compounds is reasonably different from the 100% inhibition control, hence, inhibitory hits can be identified from the assay.
Supplementary Figure S6
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Supplementary 'P' is defined as the octanol/water partition coefficient of the neutral species:
'D' is defined as the octanol/water distribution coefficient taking into account ionization:
Supplementary methods
Yeast, media and compounds
Saccharomyces cerevisiae strain SGY1528 (W303, MATα, ade2-1, canl-100, his3-11,15, leu2-3,112, trp1-1, ura3-1, trkl::HIS3, trk2::TRP1) was transformed using the lithium-chloride method and cultivated at 30 o C using standard techniques 4 in synthetic liquid media without uracil (Ura, for plasmid selection) and methionine (Met, to drive K 2P 2.1 (TREK-1) expression from the MET25 promoter of the pYES2-MET25 vector). Synthetic media, estimated to contain ~5 µM potassium 5 dye penetrate into the cells. Resazurin signals were quantified using an automated plate reader at 560 nm excitation/590 nm emission settings.
Compounds having screening scores of 44% -92% inhibition were chosen for further evaluation as this range encompassed the range of 1.25σσ-3σ above the mean inhibition of the test population (10% inhibition). Pilot screens showed that many of the compounds scoring 100% inhibition included many known antifungals. Hence, the cutoff of 92% was chosen to try to avoid enrichment of generally toxic compounds among the initial leads.
Electrophysiology
Two-electrode voltage clamp recordings were performed from defolliculated stage V-VI Xenopus oocytes 24-48 hours after injection with 0.015-6.0 ng cRNA, using microelectrodes (0. The mixture was stirred at 0-5 ºC for two hours. Water was added dropwise (10 mL) followed by aq. Na 2 CO 3 , and the mixture was extracted with ethyl acetate. The combined organic layers were washed with brine and dried over sodium sulfate. After filtration, the organic layer was concentrated to give the crude tert-butyl 3-hydroxycyclobutanecarboxylate (16) as a white semi-solid (2.3 g, 100%), which was used in the next step without purification. p-Toluenesulphonyl chloride (4.201 g, 0.022 moles) was added to a stirring solution of crude tert-butyl 3hydroxycyclobutanecarboxylate (16, 2.30 g, 8.8 mmol) in dry pyridine (10 mL) and CH 2 Cl 2 (20 mL) at 0 ºC. The mixture was allowed to warm to room temperature and stirred under nitrogen overnight. The solvent was then removed under reduced pressure and the residue was partitioned between ethyl ether (100 mL) and 0.5 N aq. HCl (20 mL). The organic layer was separated and washed with saturated NaHCO 3 and brine, and dried (Na 2 SO 4 ). After filtration, the solvent was removed under reduced pressure and the residue purified by silica gel flash chromatography (0-50% EtOAc-hexane) to afford tert-butyl 3-(tosyloxy)cyclobutanecarboxylate (17) as a colorless oil that slowly solidified at room temperature (2.6 g, 90% yield over 2 steps). 1 
cis and trans-tert-butyl 3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylate (18).
To a stirred solution of 3,6-dichlorocarbazole (12, 694 mg, 2.94 mmol) in dry DMF (15 mL) under nitrogen was added 60% sodium hydride in mineral oil (127 mg, 3.19 mmol). The reaction mixture was stirred at room temperature for 20 min and then at 60 ºC for 30 minutes, and then cooled to rt. Solid tert-butyl 3-(tosyloxy)cyclobutanecarboxylate (17, 800 mg, 2.45 mmol) was added and the reaction mixture was stirred at 60 °C overnight. The reaction mixture was then cooled to room temperature and quenched with water and extracted with ethyl acetate. The organic layer was separated and washed with brine, Page 14 dried (Na 2 SO 4 ), filtered, and concentrated. The crude residue was purified over silica gel (0-20% ethyl acetate/hexane) to afford cis-18 as a light yellow syrup which solidified on standing (220 mg), and then trans-18 as colorless syrup which solidified on standing (580 mg). cis-18: 1 3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylic acid (ML67-29) . A mixture of cis-tertbutyl 3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylate (cis-18, 90 mg, 0.23 mmol) and lithium hydroxide monohydrate (47 mg, 1.15 mmol) in THF-MeOH (1:1, 10 mL) was stirred at room temperature overnight. The reaction mixture was then concentrated and the residue treated with water, adjusted to pH ~ 3 with 2N aq. HCl, and extracted with ethyl acetate. The organic layer was washed with brine, dried (Na 2 SO 4 ), filtered, and concentrated. The crude residue was recrystallized from EtOAc/hexane to afford cis-3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylic acid as a white solid that was further purified by preparative HPLC (C18 column, 40-80% ACN-water with 0.1% HCO 2 H) to afford the title compound (55 mg, 69% yield; 95% cis). 1 
cis-
trans-3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylic acid (ML67-17).
A mixture of trans-tert-butyl 3-(3,6-dichloro-9H-carbazol-9-yl)cyclobutanecarboxylate (trans-18, 320 mg, 0.82 mmol) and lithium hydroxide monohydrate (336 mg, 8.2 mmol) in THF-MeOH (1:1, 10 mL) was stirred at room temperature overnight and then concentrated. The residue was treated with water and adjusted to pH ~ 3 with 2N aq. HCl. The solids that precipitated out of this solution were collected by filtration, washed with water, and dried in air to afford the title compound (275 mg, >95% yield; 85% trans). 1 
Synthesis of ML67-33
Methyl 2-(phenylamino) benzoate (2) 6 . Commercially available N-phenyl anthranilic acid (1) (2.0 g, 10 mmol) in acetone (30 mL) was refluxed with dimethyl sulphate (2.0 gr, 1.55 mL, 15 mmol) and potassium carbonate (1.38 g, 10 mmol) for 2 hrs. The progress of the reaction was monitored by TLC and when reaction was judged complete, the reaction mixture was allowed to cool to room temperature and poured into crushed ice. The aqueous layer was extracted with CH 2 Cl 2 (2 x 30mL), dried over anhydrous MgSO 4 , filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with gradient elution (10 to 40% EtOAc-hexane) to afford the title compound as light yellow oil (2.1 g, 92% yield). 1 3-(9,9-dimethylacridin-10-yl)propanenitrile (5) . To a stirred solution of 9,9-dimethyl-10H-acridine (4, 0.30 g, 1.0 mmol) in acrylonitrile (8 mL) was added benzyltrimethylammonium hydroxide solution (Triton-B, 50 uL) dropwise at room temperature. A vigorous exothermic reaction occurs, after which the reaction mixture was stirred for another hour and then dissolved in EtOAc (50 mL) and filtered through a pad of silica gel, washing with more EtOAc. The filtrate was evaporated and the crude product purified by silica gel column chromatography with gradient elution (0-20% EtOAc-hexane) to afford the title compound as off white crystals (0.27 g, 73% yield Synthesis of ML67-137 2,7-dibromo-9,9-dimethyl-10H-acridine (9). To a stirred solution of 9,9-dimethyl-10H-acridine (4, 0.50 g, 2.4 mmol) in dry THF (10 mL), was added trimethylphenylammonium tribromide (PTT) (1.8 g, 4.8 mmol) in one portion. The reaction mixture was stirred overnight at room temperature. After the reaction was judged complete (TLC), the reaction mixture was poured in water (30 mL) and extracted with EtOAc (2 x 30 mL). The combined organic layers were dried over anhydrous MgSO 4 , filtered and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography with gradient elution (0 to 30% EtOAc-hexane) to afford the title compound as a light brown oil (0.6 g, 69% yield 3-(2,7-dibromo-9,9-dimethylacridin-10-yl)propanenitrile (10). To a stirred solution of 2,7-dibromo-9,9-dimethyl-10H-acridine (9, 0.20 g, 0.54 mmol) in acrylonitrile (5 mL) was added benzyltrimethylammonium hydroxide solution (50 uL) at room temperature. After the initial vigorous exothermic reaction subsided, the reaction mixture was stirred at room temperature for 1 hour. The thick reaction mixture was then diluted with EtOAc (50 mL) and the mixture filtered through a pad of silica gel and washed with more EtOAc. The filtrate was evaporated and the crude product purified by silica gel column chromatography with gradient elution (0-20% EtOAc-hexane) to afford the title compound as a light brown foam (139 mg, 61% yield 2,7-dibromo-9,9-dimethyl-10-[2- (1H-1,2,3,4 -tetrazol-5-yl)ethyl]acridine (ML67-137). A sealed tube was charged with 3-(2,7-dibromo-9,9-dimethylacridin-10-yl)propanenitrile (10, 0.1 g, 0.24 mmol), sodium azide (31 mg, 0.48 mmol), ammonium chloride (26 mg, 0.48 mmol) and DMF (5 mL). The tube was sealed under nitrogen and stirred at 120 °C overnight. After cooling, the reaction mixture was diluted with water (20 mL) and adjusted to pH~5 with 1N aq. HCl, and extracted with EtOAc. The organic layer was washed with brine, dried over anhydrous Na 2 SO 4 and concentrated. The residue was purified by silica gel column chromatography with gradient elution (0 to 5% MeOH-CH 2 Cl 2 ) to afford the title compound as a light brown foam (40 mg, 36% yield). 1 H NMR (300 MHz, DMSO-d6)  1.34
